WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE
Washington, D.C.
1700 K Street NW
Fifth Floor
Washington, DC 20006-3814
US

T202-973-8800

About Our Washington, D.C., Office

The firm's Washington, D.C., office, located just blocks away from the White House on K Street, serves the legal needs of technology, life sciences, and growth enterprises, providing services that emphasize the unique characteristics of the nation's capital.

Our D.C. office represents clients across numerous corporate, IP, regulatory, and litigation areas, including antitrust; appellate; internal and government investigations; export controls and trade; M&A; privacy and cybersecurity; patents, trademarks, and copyrights; fund formation; and IT and life sciences technology transactions.

The clients we represent out of our D.C. office range from early-stage start-ups and late-stage technology and life sciences companies to publicly held entities, as well as their board and management teams. We also represent venture capital and private equity firms, along with other investor institutions. Our clients do business in established technology and life sciences industries, including biotech, communications, computer, global generics, medical devices, and software. Our D.C. attorneys also represent innovators and leaders in the AI, digital health, digital media, energy, fintech, mobility, and social media sectors.

We have an established and growing team of regulatory professionals in our D.C. office, including practitioners focused on antitrust, consumer products, healthcare, privacy, international trade, and other areas. Our team has substantial experience before major federal agencies, including the SEC, DOJ, FDA, FTC, FCC, Department of Commerce, Department of State, and the U.S. PTO.

The antitrust team in our D.C. office advises clients with respect to mergers and acquisitions, criminal and civil investigations by government agencies, antitrust litigation, and issues involving intellectual property, consumer protection, and privacy.

Our D.C. office also has a large number of national security practice attorneys who advise clients on a broad range of FCPA, CFIUS, and export trade matters, including: the applicability of government restrictions and licensing requirements; help companies obtain government approvals; represent clients facing government inquiries and investigations; advise companies on internal and board investigations; and undertake diligence and negotiations in conjunction with investments and mergers and acquisitions.

Our fintech practice--which is anchored in our D.C. office--is at the forefront of the token, coin, and ICO market. We represent companies that raise money through token offerings, and advise companies and others that want to invest in token offerings. In addition, our attorneys advise service providers to companies issuing tokens, and form and advise cryptocurrency funds.

Our corporate experience includes facilitating the formation of technology and growth start-ups; negotiating venture capital financing; advising on complex technology and business transactions, including strategic alliances and joint ventures; preparing companies for initial public offerings, secondary offerings, and mergers and acquisitions; and addressing related tax issues.

Our litigation and counseling practices focus nationally on issues related to antitrust and trade, securities defense, corporate governance, IP, export controls and economic sanctions, and privacy and cybersecurity.

Through the seamless integration of all Wilson Sonsini offices, we leverage the institutional experience and resources of the entire firm to provide high-quality services to clients. Our proprietary collaborative systems give our attorneys immediate access to the firm's collective expertise and knowledge, enabling them to respond quickly with effective solutions for our clients.

 

 

 

Get Directions
Transportation and Directions
The metro stops located closest to Wilson Sonsini's Washington, D.C., office are Farragut North (on the Red Line) and Farragut West (on the Orange and Blue lines).

Washington Metro map

Union Station is located two miles east of the office.
Parking Information
Parking is available for a fee at the following garages located near the office:

Central Parking System
900 17th Street Northwest
202-223-8579

Colonial Parking
1025 Connecticut Avenue Northwest
202-295-8100

Monument Parking
1707 L Street Northwest #1
202-296-3087

Central Parking System
1050 17th Street Northwest
202-496-4261

Mid-Town Parking
1750 K Street Northwest
202-775-8819

Colonial Parking
1776 K Street Northwest
202-298-7124
Related News and Insights
Newsletters
The Life Sciences Report – January 2026
This latest edition features articles on reasons for optimism around 2026 life sciences fundraising, key IP priorities for biotech and biopharma following Series B financing, the default rules of joint patent rights worldwide, the evolving role of innovation theories of harm in the antitrust analysis of life science mergers, life sciences venture financings for firm clients across 2H2024 and 1H2025, and how Wilson Sonsini helped ensure Light Horse Therapeutics’ impressive debut. The report also includes details on the most recent Biotech Summit and Phoenix Conference, the LaunchBio East Coast NextGen VC Forum, the latest episodes of the NextGen VC Podcast focused on life sciences investing, and the Patents and Innovations Library for in-house IP counsel, as well as select life sciences client highlights and upcoming events.
Learn More
Newsletters
The Entrepreneurs Report: Private Company Financing Trends – Q3 2025
Wilson Sonsini is pleased to present the Q3 2025 edition of The Entrepreneurs Report. We’ve compiled a range of data on venture, convertible note, and SAFE financing transactions in which the firm was involved during the third quarter, with the objective of identifying relevant trends in activity and valuation levels for the U.S. venture capital industry in general.
Learn More
News Articles
Sarah Greenberg Honored with Sparks Award from WCEE
On November 7, 2025, Wilson Sonsini associate Sarah Greenberg was announced among the 2025 Sparks Awardees by the Women’s Council on Energy and the Environment (WCEE). The Sparks Award, launched in 2022, honors women making a mark in the early stages of their career or after a career transition, sparking innovation and significantly impacting their organization. For 40 years, WCEE has helped women in the energy and environment space advance their careers and grow their networks.
Learn More
Client Highlights
Wilson Sonsini Helps Secure Favorable Settlement for Imiracle and Shenzhen iMiracle Technology Co.
A Wilson Sonsini team recently secured a favorable settlement for Imiracle (HK) Limited and Shenzhen iMiracle Technology Co. (collectively, “iMiracle”) in litigation related to the marketing and distribution of Elf Bar-branded flavored disposable vaping devices. NJOY, a U.S.-based manufacturer of tobacco- and menthol-flavored vaping devices, had claimed that iMiracle, as well as several brick-and-mortar and online retailers, had violated the California Unfair Competition Law by marketing, selling, and/or distributing flavored vaping devices in California in violation of California’s statutory ban on flavored vaping devices. 

In January 2025, Wilson Sonsini successfully secured the dismissal of a third company, Guangdong Qisitech Co., Ltd. Following fact discovery, the firm was able to secure a favorable settlement requiring only that iMiracle not sell or ship flavored disposable vaping devices in California for as long as California’s laws regarding flavored vaping devices remain in force.
Learn More
Newsletters
The Life Sciences Report – June 2025
This latest edition features articles on succeeding in the current life sciences funding market, strategic and legal considerations in digital health combinations, the corporate practice of medicine and guidance for healthcare companies and investors, the FDA’s plan to phase out animal testing, and life sciences venture financings for clients in 2024. The newsletter also includes details on the firm’s additions of leading digital health attorney and former HHS policymaker Jodi Daniel and USPTO veteran Jean Witz, the recent LaunchBio West Coast NextGen VC Forum and Life Sciences Investment Forum, Wilson Sonsini’s LSPN “Life Sciences IP Firm of the Year” award and sponsorship of the National Inventors Hall of Fame Induction Ceremony, the latest episodes of the NextGen VC Podcast focused on life sciences investing, and the Patents and Innovations Learning Library for in-house IP counsel, as well as select life sciences client highlights, recent webinars, and upcoming events.
Learn More
News Articles
Firm Named 2024 Appellate Hot List Finalist by The National Law Journal
On August 22, 2024, Wilson Sonsini was named among the 2024 Appellate Hot List finalists for The National Law Journal Legal Awards, highlighting the top litigation and appellate work from the previous year. The law firms and attorneys recognized this year are noted for their work guiding clients through high-stakes litigation, their cutting-edge approaches to environmental, social, and corporate governance issues, as well as their diversity and inclusion initiatives. Over the past year, our litigation department has secured important victories for entertainment, technology, and life sciences clients, including Fox Corporation, Google, Hulu and Disney+, iRhythm Technologies, Pinterest, Roblox, and Standard BioTools. Winners will be announced during an awards event in Washington, D.C., in October.
Learn More
View All Related News and Insights
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.